Veralto Operating Cash Flow decreased by 41.5% to $182.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.9%, from $157.00M to $182.00M. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 6.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $224.00M | $224.00M | $224.00M | $337.00M | $156.00M | $301.00M | $243.00M | $263.00M | $115.00M | $251.00M | $224.00M | $285.00M | $157.00M | $339.00M | $270.00M | $311.00M | $182.00M |
| QoQ Change | — | +0.0% | +0.0% | +50.4% | -53.7% | +92.9% | -19.3% | +8.2% | -56.3% | +118.3% | -10.8% | +27.2% | -44.9% | +115.9% | -20.4% | +15.2% | -41.5% |
| YoY Change | — | — | — | +50.4% | — | — | — | -22.0% | -26.3% | -16.6% | -7.8% | +8.4% | +36.5% | +35.1% | +20.5% | +9.1% | +15.9% |